Compare Moderna, Inc. (MRNA) vs VanEck Rare Earth/Strategic Metals (REMX) Price & Performance

Moderna, Inc.Trade

VanEck Rare Earth/Strategic MetalsTrade

Price performance (Past 24H)

Key statistics

Moderna, Inc. vs VanEck Rare Earth/Strategic Metals — how do they compare? Moderna, Inc. trades at $59.72 (market cap $23.60B), while VanEck Rare Earth/Strategic Metals trades at $71.57. The key difference: Moderna, Inc. is trading nearer its 52-week high, VanEck Rare Earth/Strategic Metals nearer its low. Which is the better fit depends on your goals.

	MRNA	REMX
Market Cap	$23.60B	—
Sector	Health	Sector/Thematic
52-Week High	$81.80	$109.53
52-Week Low	$22.36	$49.22
Enterprise Value	$19.70B	—

View details →View details →

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

MRNA

ARKG and GNOM ETFs offer different genomic bets with varied risk and returns in 2026.24/7 Wall Street · 13 hours agoNeutral New report details 1,230+ bioinformatics deals, revealing market trends and deal structures through 2026Researchandmarkets.Com · 4 days agoNeutral View details →

REMX

View details →

About Moderna, Inc.

Moderna, Inc. operates as a clinical stage biotechnology company. The Company focuses on the discovery and development of messenger RNA (mRNA) therapeutics and vaccines. Moderna develops mRNA medicines for infectious, immuno-oncology, and cardiovascular diseases.

About VanEck Rare Earth/Strategic Metals

REMX invests in global companies involved in producing, refining, and recycling rare earth and strategic metals. It provides targeted exposure to critical minerals used in high-tech and green energy, with top holdings like Albemarle and Pilbara Minerals.